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Background: 2,3-Butanediol is a chemical compound of increasing interest due to its wide applications. It can be
synthesized via mixed acid fermentation of pathogenic bacteria such as Enterobacter aerogenes and Klebsiella
oxytoca. The non-pathogenic Saccharomyces cerevisiae possesses three different 2,3-butanediol biosynthetic
pathways, but produces minute amount of 2,3-butanediol. Hence, we attempted to engineer S. cerevisiae strain to
enhance 2,3-butanediol production.
Results: We first identified gene deletion strategy by performing in silico genome-scale metabolic analysis. Based
on the best in silico strategy, in which disruption of alcohol dehydrogenase (ADH) pathway is required, we then
constructed gene deletion mutant strains and performed batch cultivation of the strains. Deletion of three ADH
genes, ADH1, ADH3 and ADH5, increased 2,3-butanediol production by 55-fold under microaerobic condition.
However, overproduction of glycerol was observed in this triple deletion strain. Additional rational design to reduce
glycerol production by GPD2 deletion altered the carbon fluxes back to ethanol and significantly reduced 2,3-
butanediol production. Deletion of ALD6 reduced acetate production in strains lacking major ADH isozymes, but it
did not favor 2,3-butanediol production. Finally, we introduced 2,3-butanediol biosynthetic pathway from Bacillus
subtilis and E. aerogenes to the engineered strain and successfully increased titer and yield. Highest 2,3-butanediol
titer (2.29 gl-1) and yield (0.113 gg-1) were achieved by Δadh1 Δadh3 Δadh5 strain under anaerobic condition.
Conclusions: With the aid of in silico metabolic engineering, we have successfully designed and constructed S.
cerevisiae strains with improved 2,3-butanediol production.
Keywords: 2,3-Butanediol, Saccharomyces cerevisiae, Metabolic engineering, Flux balance analysis, Alcohol
dehydrogenase, OptKnockBackground
With soaring oil price but indefinitely high demand for
petroleum, various sustainable forms of alternative energy
and chemicals have been sought after. Microorganisms
are able to utilize a wide range of substrate such as plant
biomass or agricultural waste and convert them into valu-
able chemicals and biofuel. With rapid development in
microbial engineering technology, this bio-based refinery
will be more feasible in terms of cost in the future and
eventually reduce the dependency on fossil fuel.
2,3-Butanediol is an interesting metabolic product as
its derivatives can be used in wide arrays of industries
ranging from synthetic rubber, solvents and drugs. 2,3-* Correspondence: mkoh@korea.ac.kr
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reproduction in any medium, provided the orButanediol can be produced efficiently via mixed acid
fermentation with prokaryotes such as Klebsiella pneu-
monia, Klebsiella oxytoca, Enterobacter aerogenes, Serra-
tia, and Bacillus polymyxa [1]. In these bacteria,
pyruvate is first converted into α-acetolactate by aceto-
lactate synthase. In anoxic state, α-acetolactate decarb-
oxylase catalyzes the conversion of α-acetolactate into
acetoin (Figure 1, green arrow). In the presence of oxy-
gen, spontaneous decarboxylation of α-acetolactate pro-
duces diacetyl. Diacetyl reductase then converts diacetyl
into acetoin. 2,3-Butanediol is resulted from the reduc-
tion of acetoin by butanediol dehydrogenase.
Most of these bacteria, however, belong to class 2
microorganisms, which are not desirable in industrial-
scale fermentation in terms of safety regulations [2]. The
need for safe 2,3-butanediol producers are undeniably
important when 2,3-butanediol are used as precursorsThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and




















































Figure 1 Metabolic pathways for 2,3-butanediol biosynthesis and pyruvate metabolism in S. cerevisiae. Green arrow shows the bacterial
2,3-butanediol synthesis pathway through α-acetolactate decarboxylase. Blue boxes contain the S. cerevisiae innate genes, while yellow boxes
indicate the foreign genes introduced to the engineered strains.
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fully screened a GRAS (generally regarded as safe)
microorganism Bacillus amyloliquefaciens B10-127 that
has high yield (0.42 gg-1glucose) and could produce up
to 92.3 gl-1 of 2,3-butanediol during fed-batch fermenta-
tion [3]. The model eukaryotic microorganism Saccharo-
myces cerevisiae which is widely used in the industry is
also a promising host microorganism.
In S. cerevisiae, acetaldehyde, pyruvate and α-
acetolactate are the precursors of 2,3-butanediol (Fig-
ure 1). The biosynthetic pathway with diacetyl as inter-
mediate is similar with that of the bacteria’s. However, α-
acetolactate decarboxylase is not found in most of the S.
cerevisiae strain. Instead, S. cerevisiae can synthesize
acetoin via the condensation of active acetaldehyde with
acetaldehyde by pyruvate decarboxylase [4]. In addition,
the carboligase mechanism of pyruvate decarboxylase
for the synthesis of acetoin from the reaction between
pyruvate and acetaldehyde has been elucidated previ-
ously [5]. Acetoin is then converted into 2,3-butanediol
by butanediol dehydrogenase.
Hitherto, there are few reports regarding 2,3-butane-
diol production by engineered S. cerevisiae strain. 2,3-Butanediol production has been favored over acetoin
and diacetyl in beer and wine fermentation due to its
neutral organoleptic characteristics. Diacetyl production
in brewing process is undesirable due to its unpleasant
flavor and its low taste threshold. Previous attempts
successfully reduced the diacetyl production in brewer’s
yeast by expressing heterologous α-acetolactate decarb-
oxylase from Klebsiella terrigena and Enterobacter
aerogenes [6,7]. 2,3-Butanediol which has a higher fla-
vor threshold than diacetyl is subsequently produced
as the final product. Other than that, overexpression
of GPD1 in wine yeast strains also led to increased
2,3-butanediol production [8]. Recently, Ehsani et al.
[9] have shown that by the overproduction of native
Bdh1p or by changing the coenzyme specificity of
BDH1 of a strain that overproduces glycerol and lacks
ALD6, they manage to yield 0.0307 - 0.033 gg-1 of
2,3-butanediol in synthetic medium that simulated
standard grape juice. Nevertheless, the focus of previ-
ous attempts did not target 2,3-butanediol as the main
product.
Despite possessing more than two innate pathways
that led from pyruvate to 2,3-butanediol [10], the
Ng et al. Microbial Cell Factories 2012, 11:68 Page 3 of 14
http://www.microbialcellfactories.com/content/11/1/68productivity is extremely poor in wild-type S. cerevisiae
strain when compared with bacteria[2]. We believed that
the capability of S. cerevisiae in producing 2,3-butanediol
can be further improved. For this purpose, computa-
tional strain design and optimization procedures can
guide researcher in seeking for the best metabolic engin-
eering strategy that coupled product formation with
cellular objective such as growth [11]. Several genome-
scale reconstruction models of yeast have been pub-
lished previously [12-15]. Using these constraint-based
stoichiometric models of yeast, we can predict the meta-
bolic flux redistribution in a strain caused by a genetic
or an environmental perturbation by flux balance ana-
lysis (FBA) methods [16,17].
OptKnock framework[18] was one of the earliest
FBA-based algorithms being developed to predict gene
deletion strategies for the overproduction of a target
chemical while maximizing the cellular objective such as
growth. Since then, this algorithm has been successfully
applied to design Escherichia coli strain for the overpro-
duction of lactate [19], malonyl-CoA [20] and 1,4-buta-
nediol [21]. In comparison with E. coli stoichiometric
models, the eukaryote S. cerevisiae models are compart-
mentalized and more complex in terms of its metabolic
network. Constraint-based modeling approach for chem-
ical overproduction in S. cerevisiae has been received
with mixed opinions [22-24]. Kennedy et al. demon-
strated a successful FBA-based design approach for the
production of formic acid, a non-fermentative metabolite
in yeast [25]. Meanwhile, Bro et al. has applied the
genome-scale cell model of S. cerevisiae to construct a
strain with 40% reduced glycerol yield and increased
ethanol yield [26].
In this paper, we attempted to engineer S. cerevisiae
strain for the production of 2,3-butanediol. To
achieve this objective, in silico strain design was per-
formed with a recently published S. cerevisiae
genome-scale metabolic model of yeast, iMM904 [13].
OptKnock algorithm identified genes that have to be
deleted for the overproduction of 2,3-butanediol.
Based on the in silico prediction, we constructed a
few strains with different combinations of gene dele-
tions and quantitatively analyzed the extracellular
metabolites in batch fermentations. We also evaluated
whether two other strategies that would reduce by-
products and increase pre-cursors of 2,3-butanediol
will favor its production: 1. deletion of a NADP+
dependent aldehyde dehydrogenase encoded by ALD6
and 2. deletion of NADH dependent glycerol-3-
phosphate (G3P) dehydrogenase encoded by GPD2.
Finally, we compared the effect of the amplification
of S. cerevisiae innate 2,3-butanediol biosynthesis
pathway with the introduction of bacterial pathway to
different engineered host strains.Results and discussion
In silico design of 2,3-butanediol producing strain using
OptKnock
The flux through butanediol dehydrogenase leading to
the biosynthesis of R,R-2,3-butanediol was being consid-
ered as our bioengineering objective and biomass pro-
duction as the cellular objective in OptKnock. All
simulations were performed under aerobic condition
with glucose as the substrate. We could not identify sin-
gle reaction deletion or double reaction deletion strategy
that will yield significant amount of 2,3-butanediol in
iMM904 model.
As we proceeded with higher numbers of reactions for
deletion, we initially obtained model C and model D
with four and five target reactions respectively (Table 1).
Both models include the deletion of pyruvate dehydro-
genase (PDH) complex and glutamate dehydrogenase.
The former is a mitochondrial multi-protein complex
that catalyzes the conversion of pyruvate to acetyl-coA
with concomitant generation of NADH [27]. With the
deletion of this reaction, more flux from the pyruvate
node could be redistributed towards the bioengineering
objective. However, the deletion of PDH reaction
reduces NADH formation that would favor 2,3-butane-
diol production. Other than that, the deletion of PDH
complexes required deletion of up to five genes encod-
ing different subunits that formed the complex. The
NADPH dependent glutamate dehydrogenase encoded
by GDH1and GDH3 genes is responsible for glutamate
biosynthesis and has a vital role in ammonium metabol-
ism in yeast. It has been reported that deletion of GDH1
increased ethanol formation and reduced glycerol forma-
tion in wild-type strain but reduced growth [28]. We
could not clearly interpret the other reactions predicted
in model C and D as they are non-intuitive. Aspartate
transaminase is an important enzyme in amino acid me-
tabolism that catalyzes the reversible conversion of as-
partate and α-ketoglutarate to glutamate and
oxaloacetate. NAD kinase is responsible for the phos-
phorylation of NAD+ to NADP+; but the combination of
POS5 and UTR1 genes deletion is synthetically lethal
[29]. Meanwhile, cytidylate kinase and nucleoside di-
phosphate kinase are reactions in nucleotide salvage
pathway, whereas thymidine phosphorylase is an enzyme
in purine and pyrimidine biosynthesis pathway (Add-
itional file 1(a)).
By removing these reactions from the set of target
reactions for knockout, we managed to obtain model A.
In this model, elimination of all alcohol dehydrogenase
(ADH) reactions was proposed. 2,3-Butanediol and etha-
nol not only share the same precursor molecules, which
are pyruvate and acetaldehyde; the conversion of these
precursor molecules to 2,3-butanediol and ethanol also
require the input of NADH. Thus, removal of the highly









WT - - 0.288 0
A 1. ALCD2ir: ADH1, ADH4, ADH5 0.231 0.313
2. ALCD2irm ADH3
3. ALCD2x SFA1




C 1. GLUDyi GDH1, GDH3 0.266 0.151
2. NADK UTR1, UTR2, POS5
3. NDPK3 YNK1
4. PDHm PDB1, PDA1, LAT1,
LPD1, PDX1
D 1. ASPTA AAT2 0.264 0.151
2. CYTK1 -
3. GLUDyi GDH1, GDH3
4. PDHm PDB1, PDA1, LAT1,
LPD1, PDX1
5. TMDPP PNP1
* Additional descriptions are provided in Additional file 1.
The maximum specific growth rate and R,R-2,3-butanediol yield were calculated based on 10 mmolgDCW-1.hr-1 of glucose uptake. WT stands for the complete
network of iMM904 model.
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may favor the production of 2,3-butanediol by increasing
the supply of pyruvate, acetaldehyde and NADH. Even
though this strain has a growth rate 20% lower than that
of the reference strain, it is predicted to yield 0.313 gg-1
glucose of 2,3-butanediol (Additional file 1(b)).
Another quadruple deletion mutant strain with 15%
higher yield of 2,3-butanediol was also proposed as a solu-
tion. In addition to the cytosolic ADH reaction of model
A, cytosolic malate dehydrogenase (MDH2), which con-
verts malate to oxaloacetate with a concomitant reduction
of NAD+, was suggested as a target reaction. This gluco-
neogenic reaction is subject to glucose repression. How-
ever, during simulation with iMM904 model, this flux
showed negative value for glucose grown wild-type strain,
suggesting that the opposite reaction is active. OptKnock
might have suggested the deletion of this reaction, which
competes for NADH with 2,3-butanediol. The reason for
GTP cyclohydrolase deletion is unknown. Furthermore,
this quadruple deletion mutant has a growth rate equal to
66% of the reference strain.
Due to the large number of reactions in the genome
scale metabolic model, computational strain design with
OptKnock produced some non-intuitive deletion strat-
egies that are difficult for logical interpretation. Though,
OptKnock has predicted the deletion of PDH and ADHreactions, which are highly competitive for the carbon
flux to 2,3-butanediol, as our strain design strategies.
Since model A and model B have higher 2,3-butanediol
yields than model C and model D (Table 1), we decided
to evaluate the deletion of the ADH reaction that is
required in both model A and model B.
Strain construction and microaerobic fermentations
To test this hypothesis provided by OptKnock, we would
have to delete all the genes that are responsible for the
conversion of acetaldehyde to ethanol. A total of four
ADH genes, ADH1, ADH3, ADH4 and ADH5, along
with SFA1 gene have to be disrupted. Previous report
[30] showed that ADH4 gene product does not contrib-
ute to ethanol production. Meanwhile, SFA1 is known as
a long-chain ADH [31] and formaldehyde dehydrogen-
ase [32]. Therefore, our target genes for deletion were
reduced to three – ADH1, ADH3 and ADH5.
To identify the contribution of each gene deletion to
2,3-butanediol yield, we have constructed deletion strains
with different combination of the three ADH genes
(Table 2). Shake-flask cultivations were then performed
with these strains at microaerobic condition. Engineered
strains took longer time (~ 60 h) to complete fermenta-
tion than the wild-type strain (~ 40 h). Only up to
0.04 gl-1 of 2,3-butanediol (0.002 gg-1) was detected in
Table 2 S. cerevisiae strains used in this study
Strain Genotype Reference
BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 EUROSCARF
B2C-a1 BY4742 Δadh1::loxP This study
B2C-a1a3 BY4742 Δadh1::loxP Δadh3::loxP This study
B2C-a1a5 BY4742 Δadh1::loxP Δadh5::loxP This study
B2C-a1a3a5 BY4742 Δadh1::loxP Δadh5::loxP Δadh3::loxP This study
B2C-a1a6 BY4742 Δadh1::loxP Δald6::loxP This study
B2C-a1a3a6 BY4742 Δadh1::loxP Δald6::loxP Δadh3::loxP This study
B2C-a1a5a6 BY4742 Δadh1::loxP Δald6::loxP Δadh5::loxP This study
B2C-a1a6g2 BY4742 Δadh1::loxP Δald6::loxP Δgpd2::loxP This study
B2C-a1a3a5a6g2 BY4742 Δadh1::loxP Δald6::loxP Δgpd2::loxP Δadh3::loxP Δadh5::loxP This study
B2C-SB BY4742 p423GPD-BDH1 This study
B2C-ABC BY4742 p423GPD-budC pCTP-URA::TEF1p-alsS + PGK1p-budA This study
B2C-a1a5-SB BY4742 Δadh1::loxP Δadh5::loxP p423TEF-BDH1 This study
B2C-a1a5-ABC BY4742 Δadh1::loxP Δadh5::loxP p423GPD-budC pCTP-URA::TEF1p-alsS + PGK1p-budA This study
B2C-a1a6-SB BY4742 Δadh1::loxP Δald6::loxP p423GPD-BDH1 This study
B2C-a1a6-ABC BY4742 Δadh1::loxP Δald6::loxP p423GPD-budC pCTP-URA::TEF1p-alsS + PGK1p-budA This study
*Genotype is described in the order of the corresponding genetic manipulations.
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with the wild-type strain, single deletion of the major
ADH gene ADH1 reduced ethanol yield by almost half
and increased 2,3-butanediol yield by up to 20.5-fold,
with a 2,3-butanediol maximum titers and product yields
of 0.825 gl-1 and 0.041 gg-1, respectively (Figure 2 and
Table 3). The double deletion strains B2C-a1a3 (Δadh1
Δadh3) and B2C-a1a5 (Δadh1 Δadh5) produced up to
1.54 gl-1 and 1.42 gl-1 of 2,3-butanediol, respectively,
with a 2,3-butanediol yield of 85% - 88% more than the
Δadh1 single deletion strain. Strain B2C-a1a3a5, of which
three ADH isozymes encoded by ADH1, ADH3 and
ADH5 genes were deleted, achieved the highest 2,3-
butanediol titer and yield among the engineered strains,
up to 1.64 gl-1 and 0.093 gg-1. This triple deletion strain
produced 73.3% lesser ethanol than wild-type strain.
Consistent with previous reports [33,34], this strain still
retains its ability to produce ethanol due to residual
ADH isozymes. It has higher 2,3-butanediol yield per
substrate than strain B2C-a1a3 and strain B2C-a1a5
owing to the fact that up to 2.41 gl-1 of residual glucose
was detected at the end of fermentation.
Previous works stated that acetaldehyde accumulation
in Δadh1 strain led to poor growth in glucose [34,35].
Acetaldehyde at a level higher than 0.3 gl-1 inhibits cell
growth [36]. We found that the concentrations of acetal-
dehyde in the supernatant at the end of fermentation
were significantly higher in deletion strains (B2C-a1,
B2C-a1a3, B2C-a1a5 and B2C-a1a3a5) than the wild-
type strain (Table 3). Accordingly, the final biomass
yields for these deletion strains were highly reduced. Wealso thought that perhaps the high acetaldehyde level in
the supernatant, which is toxic to the cells, causes the
cessation in glucose uptake of some of the deletion
strains. In addition, deletion strains also exhibited 22-
71% higher level of acetate and 6 - 8-fold increase in
glycerol level over wild-type strain. Analysis of strain
lacking ADH1 or ADH1-4 isozymes previously has
shown that glycerol is the main fermentation product
for these strains, while acetaldehyde and acetate are pro-
duced in significant amounts [30]. This is because redu-
cing the flux towards ethanol led to the accumulation of
NADH and acetaldehyde. Generation of glycerol allows
the strain to reoxidize excess NADH in the cytosols,
while acetate formation reduces the acetaldehyde accu-
mulated. Nevertheless, 2,3-butanediol production in
these strains has not been reported. 2,3-Butanediol can
be synthesized directly from pyruvate via yeast innate
pathway. Production of 2,3-butanediol requires the oxi-
dation of NADH, whereas oxidation of acetaldehyde to
acetate reduced the cofactor NAD(P)+. Thus, accumula-
tion of acetaldehyde in strains B2C-a1, B2C-a1a3 and
B2C-a1a5 strains greatly increased the production of
2,3-butanediol. The results of additional gene deletion
strategies to reduce by-products (acetate and glycerol)
and their effect on 2,3-butanediol production are dis-
cussed in the next sections.
Production of 2,3-butanediol in the engineered strain
mostly occurs through the pathways that are catalyzed
by pyruvate decarboxylase. Deletion of PDC1 from
Δadh1 background was reported to reduce acetaldehyde

























































Figure 2 Extracellular metabolite concentrations for batch cultivation. Concentration of (a) 2,3-butanediol, (b) ethanol, (c) acetate and (d)
glycerol at the end of batch cultivation under microaerobic conditions. Plus or minus signs indicate presence or absence of the corresponding
gene deletion. The first column corresponds to the wild-type strain. Error bars represent standard deviations associated with four independent
experiments (except for strains B2C-a1, B2C-a1a5a6, B2C-a1a3a5a6g2, where n = 3; and for strains B2C-a1a3a5 and B2C-a1a3a6, where n = 2).
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published observations). Deletion of PDC1 from Δadh1
strain reduced the flux towards acetaldehyde and conse-
quently decreased acetoin production. This attested that
pyruvate decarboxylase enzyme is important in the pro-
duction of acetaldehyde and the production of 2,3-
butanediol. Nevertheless, the acetoin synthase activity of
pyruvate decarboxylase enzyme has been reported to
reach saturation level [5] at a very low concentration
and increase only by 10% even with larger pool of acetal-
dehyde. So, further deletion of more ADH genes did notresulted in a more drastic increase in 2,3-butanediol
production.
The effect of ALD6 gene deletion on 2,3-butanediol
production
ALD6 gene encodes the main cytosolic aldehyde de-
hydrogenase that catalyzes the conversion of acetalde-
hyde to acetate. Eglinton et al. has shown that acetic
acid production can be reduced in glycerol overprodu-
cing strain of S. cerevisiae by deleting the ALD6 gene
[38]. As discussed in the previous section, strains B2C-











2,3-Butanediol Glycerol Ethanol Acetoin Acetate
BY4742 40 1.349 0 0.118 0.002 0.032 0.417 0 0.017
B2C-a1{ 56 0.787 0 0.663 0.041 0.225 0.243 0.016 0.02
B2C-a1a3 54 0.876 0 1.194 0.076 0.254 0.166 0.012 0.029
B2C-a1a5 72 0.634 1.80 1.106 0.079 0.295 0.123 0.010 0.024
B2C-a1a3a5† 54 0.900 2.41 1.316 0.093 0.238 0.131 0.008 0.025
B2C-a1a6 57 0.740 0.09 0.493 0.046 0.265 0.231 0.010 0.002
B2C-a1a3a6† 63 0.619 0.78 0.312 0.023 0.125 0.318 0.011 0
B2C-a1a5a6{ 54 0.842 0 0.263 0.033 0.247 0.259 0.011 0
B2C-a1a3a5a6g2{ 64 0.806 0 0.220 0.018 0.081 0.347 0.007 0
*All cultures were performed with an initial concentration of 20 gl-1 of glucose under microaerobic condition. The extracellular metabolite concentrations and
yields (g metabolite produced/g glucose consumed) were determined at the time of glucose exhaustion or when the strains ceased to consume glucose.
Fermentation time indicates the mean time of the end of fermentation. Residual glucose indicates the amount of glucose detected in the supernatant at the end
of fermentation.
** All data correspond to the mean of four independent experiments (n = 4) unless indicated. For all data, standard error of the mean is lower than 10%.
{ Data correspond to the mean of three independent experiments (n = 3).
† Data correspond to the mean of two independent experiments (n = 2).
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more acetate when compared to the wild-type strain.
High production of acetic acid lowers the pH of the
culture broth and can induce programmed cell death in
S. cerevisiae cells [39]. So, we investigated the effect of
ALD6 deletion on the production of 2,3-butanediol in
the engineered strains with deletion in one or more
ADH genes.
Deletion of ALD6 significantly reduced the production
of acetate in all the engineered strains, from an average
of 0.47 gl-1 to undetectable level (Figure 2). However,
this decrease in acetate did not correspond to the in-
crease in 2,3-butanediol production in most of the engi-
neered strains. Only strain B2C-a1a6 showed a slight
increase in 2,3-butanediol yield when compared to its
parent strain (B2C-a1), from 0.041 gg-1 to 0.046 gg-1.
On the contrary, the 2,3-butanediol yield of B2C-a1a3a6
was equal to only 30% of strain B2C-a1a3. Similarly,
strain B2C-a1a5a6 had a 58% lower 2,3-butanediol yield
than strain B2C-a1a5 (Table 3).
We had initially anticipated that deletion of the alde-
hyde dehydrogenase gene, ALD6, in strains that con-
tained one or more deleted ADH genes would lead to
the accumulation of acetaldehyde. This acetaldehyde
could then be converted to acetoin through pyruvate de-
carboxylase reaction and consequently improve 2,3-
butanediol yield. In contrast to our initial hypothesis,
strains B2C-a1a5a6 and B2C-a1a3a6 yielded higher levels
of ethanol and lower levels of acetaldehyde than strains
B2C-a1a5 and B2C-a1a3 which harbor the native ALD6
gene. This suggests an increase in the activity of the
remaining ADH isozymes of these mutant strains as a
survival mechanism of the cells due to the toxicity ofacetaldehyde. These residual ADH isozymes compete
more efficiently for acetaldehyde than the acetoin-
synthesizing pyruvate decarboxylase, which is another
pathway for acetaldehyde detoxification. Similarly, Rou-
stan et al. [40] have reported that the ADH activity of
wine yeast increased when acetaldehyde was added to
the stationary phase medium of wine fermentation.
The effect of GPD2 gene deletion on extracellular
metabolite yields
In strains carrying deletion of ADH1, excess G3P is pro-
duced by G3P dehydrogenase from dihydroxyacetone
phosphate while regenerating NAD+. Glycerol is then
formed by the dephosphorylation reaction of glycerol-3-
phosphatase. Two strains (B2C-a1a6 and B2C-a1a3a5)
that produced glycerol as the major fermentation prod-
uct under microaerobic condition were evaluated for the
effect of the disruption of G3P dehydrogenase reaction.
GPD1 and GPD2 encode the isozymes of G3P de-
hydrogenase. It has been shown that the deletion of both
genes cease glycerol production in S. cerevisiae cells
[41]. Nevertheless, deletion of both genes was lethal in
strain B2C-a1a6 as the cell lost the ability to re-oxidize
excess NADH and produce ATP. Single deletion of the
osmoregulated GPD1 in Δadh1 Δald6 background has
minor effect in the reduction of glycerol production
(data not shown). On the contrary, the deletion of GPD2
in strain B2C-a1a6 reduced glycerol production when
compared to the double deletion strain (Figure 3). GPD2
activity is affected by redox control. The limitation in
NADH re-oxidation ability due to the deletion of ADH1
in strain B2C-a1a6, as well as the low oxygen condition
during microaerobic cultivation, contributes to the





















Figure 3 The effect of GPD2 deletion on 2,3-butanediol, glycerol and ethanol yields. Metabolite yields for strains (a) BY4742, (b) B2C-a1a6,
(c) B2C-a1a6g2, (d) B2C-a1a3a5 and (e) B2C-a1a3a5a6g2 at the end of batch cultivation under microaerobic condition. Columns and error bars
correspond to the mean value and standard deviations of four independent experiments for (a) and (b), duplicate experiments for (c) and (d) and
triplicate experiments for (e).
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induced. The increase in pyruvate and NADH due to
GPD2 deletion, however, did not favor 2,3-butanediol
production in strain B2C-a1a6g2 as ethanol became the
major fermentation product. Similarly, deletion of both
ALD6 and GPD2 from strain B2C-a1a3a5 also com-
pletely altered the final product composition of the
medium. The quintuple deletion strain displayed lower
yield of 2,3-butanediol and glycerol, but higher yield of
ethanol (Table 3).
In strains with ADH1 deletion, glycerol is greatly
produced to regenerate the reducing equivalents [34].
By reducing the ability of the cells to oxidize excess
NADH through glycerol production, ethanol was again
produced as major fermentation product in strains
B2C-a1a6g2 and B2C-a1a3a5a6g2. It is possible that
the expressions of the remaining ADH genes were
induced to cope with the NADH surplus condition.
This is because the synthesis of two moles of ethanol
from one mole of pyruvate and one mole of acetalde-
hyde consumes twice the amount of NADH that is
required for the formation of one mole of 2,3-butane-
diol from the same amount of precursor molecules
[40].
Anaerobic batch fermentation
In order to test whether 2,3-butanediol production can
be improved in a highly fermentative condition, strains
B2C-a1a5, B2C-a1a6, B2C-a1a3a5 and wild-type strain
BY4742 were selected for anaerobic batch cultivation. In
the absence of oxygen, S. cerevisiae cells are known to
produce significant amount of ethanol and glycerol as amean to maintain redox balance and generate ATP in
the cells. Due to slower growth in anaerobic state, the
biomass yield of wild-type and all engineered strains
were greatly reduced while the fermentation time
increased significantly. All strains exhibited higher gly-
cerol yield due to anaerobiosis. Meanwhile, a decline in
the production of the more oxidized acetate was
observed in wild-type and the engineered strains
(Figure 4).
With deficiency in its ADH genes, the engineered
strains B2C-a1a5, B2C-a1a6 and B2C-a1a3a5 produced
glycerol as the major fermentation product. Under
microaerobic condition, the second major by-product
was ethanol, followed by 2,3-butanediol. Interestingly,
growth in anoxic state led to the opposite case for
strains B2C-a1a5 and B2C-a1a3a5, where 2,3-butanediol
yield was higher than ethanol yield (Figure 4). In com-
parison to the microaerobic state, the yield of ethanol in
anaerobic state was lowered by more than 34% and 24%
for strains B2C-a1a5 and B2C-a1a3a5, respectively. Up
to 2.29 gl-1 of 2,3-butanediol was detected in the fer-
mentation broth for the triple deletion strain, with a
yield of 0.113 gg-1 (Figure 5). 2,3-Butanediol was not
detected in wild-type strain culture broth under anaer-
obic condition.
An intriguing relationship between the level of oxygen
with the production concentration of 2,3-butanediol and
ethanol can be deduced from our observation. 2,3-
Butanediol yield correlates inversely with the level of
oxygen and thus the biomass yield. As low oxygen is
known to led to higher fermentative energy metabolism































Figure 4 Metabolite profile of cultivation under microaerobic (M) and anaerobic (A) conditions. The bar chart shows glycerol, 2,3-
butanediol, ethanol and acetate yields for batch fermentation of (a) BY4742, (b) B2C-a1a5, (c) B2C-a1a6 and (d) B2C-a1a3a5 under microaerobic
condition and anaerobic condition with 20 gl-1 of glucose as substrate. Error bars represent standard deviations.
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http://www.microbialcellfactories.com/content/11/1/68fermentation products under anaerobic condition. It is
harder to interpret the connection between 2,3-
butanediol and ethanol when combined with oxygen
level. Since 2,3-butanediol and ethanol shares the same
precursor molecule, their concentrations should correl-
ate in an inverse manner. We suspected that the rate of
acetaldehyde formation determines the amount of etha-
nol and 2,3-butanediol produced. However, we could
not track the dynamic changes in the concentration of
intracellular acetaldehyde in this study.((a)
Time (h)

























































Figure 5 Changes in metabolite concentrations for strains (a) BY4742
Glucose (brown circles), OD660nm (black circles), glycerol (inversed triangles)
concentrations are shown. Symbols and error bars represent the mean andImproved 2,3-butanediol yield by gene overexpression
strategies
In this section, we compared the single overexpression
of innate BDH1 and introduction of additional 2,3-buta-
nediol synthesis pathway from bacteria in three different
host: wild-type strain, strain B2C-a1a5 and strain B2C-
a1a6. The heterologous pathway was introduced by the
co-expression of B. subtilis alsS gene, E. aerogenes budA
gene and E. aerogenes budC gene using two multicopy
plasmids (Table 4). We used the acetolactate synthase ofb)
Time (h)


























































(wild-type) and (b) B2C-a1a3a5 under anaerobic condition.
, 2,3-butanediol (squares), ethanol (diamonds) and acetate (triangles)




























Figure 6 Comparison of 2,3-butanediol yield with gene
overexpression strategies. Each bar represents the 2,3-butanediol
yield for shake-flask cultivation under microaerobic condition for
three different host strains: (a) BY4742, (b) B2C-a1a5 and (c) B2C-
a1a6 expressing . Red bars, host strain (reference); yellow bars,
overexpression of S. cerevisiae innate BDH1; green bars, bacterial alsS-
budA-budC co-expression. Values and error bars correspond to the
mean and standard deviation for triplicate experiments (except for
all the red bars, where four independent experiments were
conducted).
Table 4 Plasmid used in this study
Plasmid Description Reference
pFA6a-KanMX6 E. coli kanr gene under the control of Ashbya gossypii TEF promoter-driven [45]
pCNKanMX6 loxP flanking KanMX6 at SalI/BamHI and SacI/EcoRV sites This study
pTKURA3 loxP flanking S. cerevisiae URA3 gene This study
p423GPD 2 μ, HIS3, PGPD1 [46]
p423TEF 2 μ, HIS3, PTEF1 [46]
p423GPD-BDH1 S. cerevisiae BDH1 gene under the control of GPD1 promoter in p423GPD This study
p423TEF-BDH1 S. cerevisiae BDH1 gene under the control of TEF1 promoter in p423GPD This study
p423GPD-E.a.budC E. aerogenes KCTC 2190 budC gene under the control of GPD1 promoter in p423GPD This study
pESC-URA 2 μ, URA3, PGAL10 PGAL1 Stratagene
pESC-LEU 2 μ, LEU2, PGAL10 PGAL1 Stratagene
pESC-LEU-Cre P1 bacteriophage Cre recombinase under the control of GAL10 promoter This study
pCTP-URA 2 μ, URA3, PTEF1 PPGK1 This study
pCTP-URA::TEF1p-alsS + PGK1p-budA Bacillus subtilis alsS gene under the control of TEF1 promoter and E.
aerogenes KCTC 2190 budA gene under the control of PGK1 promoter in pCTP-URA
This study
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preference for pyruvate over 2-ketobutyrate [42]. On the
contrary, S. cerevisiae native acetolactate synthase
encoded by ILV2 has higher affinity for 2-ketobutyrate.
E. aerogenes budA encodes α-acetolactate decarboxylase,
which is absent in S. cerevisiae strain. The E. aerogenes
2,3-butanediol dehydrogenase, encoded by budC, dis-
plays higher affinity for both NADH and acetoin (Km,
NADH= 5–7 μM and Km,acetoin = 0.4 mM) than the S. cer-
evisiae native Bdh1p (Km,NADH = 45 μM and Km,acetoin = 3
mM) [43,44]. The mRNA expression levels of all the
genes in the strains we constructed have been confirmed
by real-time PCR (data not shown).
In the wild-type strain, overexpression of BDH1 and the
bacterial pathway genes increased 2,3-butanediol yield by
2.4-fold and 11.1-fold, respectively (Figure 6). However,
the yield of these strains is very low when compared with
the deletion strains. The introduction of acetolactate
decarboxylase pathway managed to double the yield of
2,3-butanediol in strain B2C-a1a6 to 0.089 gg-1. In the
engineered strain B2C-a1a5, 2,3-butanediol yield was only
slightly affected by the overexpression of endogenous
butanediol dehydrogenase gene. The introduction of the
heterologous pathway, however, successfully increased
2,3-butanediol yield by 22% when compared with its par-
ent strain B2C-a1a5. Despite the small enhancement of
2,3-butanediol yield, strain B2C-a1a5-ABC produced the
highest titer of 2,3-butanediol, with up to 1.67 gl-1, corre-
sponding to 2,3-butanediol yield of 0.096 gg-1 during
microaerobic shake-flask culture.
In wild-type strain and strain B2C-a1a5, overexpres-
sion of BDH1 rendered minimal effect on 2,3-butanediol
yield. It seems likely that butanediol dehydrogenase reac-
tion is not the bottleneck in 2,3-butanediol biosynthetic
pathways in these strains. This is because the fluxtowards acetoin was probably not adequate in the wild-
type strain expressing BDH1; whereas in the case of
strain B2C-a1a5, it is possible that the conversion of
acetaldehyde to acetoin is the rate-limiting step as sig-
nificant amount of acetaldehyde accumulated in the
medium (Table 3). Strain B2C-a1a6 is the only host
strain that demonstrated a greater increase in 2,3-
butanediol yield due the amplification of BDH1. It is also
surprising that this strain yielded more 2,3-butanediol
than ethanol (0.0887 gg-1 and 0.0713 gg-1, respectively)
when the bacterial pathway genes are introduced. How-
ever, this strain (B2C-a1a6-ABC) only managed to
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fermentation medium under microaerobic condition im-
plicating that the cell growth was greatly inhibited by
certain metabolites or its cellular redox state is highly
imbalanced (Data not shown). To enhance the overall
flux from pyruvate to 2,3-butanediol in S. cerevisiae, our
data in this section suggests that the overexpression of
budC or BDH1 together with alsS and budA can be an
alternative to forcing carbon fluxes through the rate-
limiting pyruvate decarboxylase pathway.
Conclusions
In silico S. cerevisiae strain design for the production of
2,3-butanediol suggested the deletion of mitochondrial
and cytosolic ADH genes. We thus constructed deletion
strains with low ADH activity by the deletion of ADH1,
ADH3 and ADH5 genes. Single deletion of major cyto-
solic ADH gene ADH1 increased the production titer by
around 21-fold. Detoxification mechanism of cells as a
response to increased acetaldehyde pool [8], along with
the failure to regenerate excess NADH efficiently
through ethanol production stimulate 2,3-butanediol
production in the deletion strains. Further reduction of
ADH activity by additional disruption of ADH3 or
ADH5 or both genes increased production by ~2-fold
when compared to single deletion strain. But distinct-
ively higher production was not observed, showing that
the maximal conversion of acetaldehyde to acetoin and
subsequently to 2,3-butanediol has been achieved by re-
ducing ADH activity. High accumulation of acetaldehyde
in these deletion strains also implies that the conversion
of acetaldehyde to acetoin is rate-limiting. We have thus
shown that 2,3-butanediol production can be enhanced
in the engineered strains through the introduction of
foreign biosynthetic pathway. Further improvement of
the conversion efficiency of precursor molecules to 2,3-
butanediol have to be considered in future study.
OptKnock framework has suggested a deletion strategy
that led us to the hypothesis that increase in NADH,
acetaldehyde and pyruvate could improve 2,3-butanediol
production. This is supported by our data with strains
lacking major ADH genes. Nevertheless, this hypothesis
is true only to a certain extent as rational deletion strat-
egies based on this hypothesis, including ALD6 deletion
to accumulate acetaldehyde and GPD2 deletion to fur-
ther increase NADH and pyruvate in strains with low
ADH activity, did not enhance 2,3-butanediol produc-
tion but increased ethanol formation instead. Problems
remained to be solved to further engineer the industrial
workhorse S. cerevisiae for 2,3-butanediol production.
In conclusion, we have demonstrated a successful im-
plementation of in silico guided metabolic engineering
approach for the production of a fermentative product
in S. cerevisiae. 2,3-Butanediol producing S. cerevisiaestrains were constructed by referring to OptKnock’s pre-
diction. Currently, among all the engineered strains,
strain B2C-a1a3a5 (Δadh1 Δadh3 Δadh5) achieved the
highest 2,3-butanediol titer and yield under anaerobic
condition (2.29 gl-1 and 0.113 gg-1). To our knowledge,
this is the first ever report about 2,3-butanediol produc-




FBA-based simulation and strain design using OptKnock
algorithm [18] were performed in Matlab R2010a (The
MathWorks, Inc., Massachusetts, USA) with the
COBRA Toolbox v2.0 [47]. Gurobi Optimizer 4.5 (Gur-
obi Optimization, Houston, USA) was used to per-
formed linear programming calculations. The recently
reported yeast genome-scale model iMM904 [13],
consisting of 904 genes, 1577 reactions and 1228 metabo-
lites, was used. All simulations were performed with the
following constraints: oxygen uptake rate, 2mmolgDCW-
1hr-1; glucose uptake, 10mmolgDCW-1hr-1; ATP
required for maintenance, 1mmolgDCW-1hr-1. We
excluded all exchange and transports reactions from the
target knockouts.
Strains, plasmid and growth conditions
All engineered strains used in this study are derived
from S. cerevisiae BY4742 strain family (BY4742 MATα
his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0). During constructions,
strains were grown and maintained on complex (YPD)
medium consisting of 1% (w/v) bacto yeast extract and
2% (w/v) yeast bacto peptone supplemented with 20 gl-1
glucose as carbon source. Transformants and strains
harboring recombinant plasmid(s) were grown on syn-
thetic complete dropout (SC) medium consisted of
20 gl-1 glucose, 6.7 gl-1 yeast nitrogen base without
amino acid (Difco, BD Biosciences) and the appropriate
amino acid supplement mixture (either CSM, CSM-
URA, CSM-HIS, CSM-LEU or CSM-HIS-URA, MP Bio-
medicals). In all cases, glucose was autoclaved separately.
Escherichia coli DH5α strain was used for amplification
of plasmids. Transformed E. coli DH5α cells were grown
at 37°C in Luria-Bertani (LB) medium containing
100ugml-1 of ampicillin.
Construction of S. cerevisiae deletion strains
All the strains used in this work are listed in Table 2.
Gene deletion of S. cerevisiae was performed by short
flanking homology PCR method with Cre/loxP system
for recycling of selection marker gene. pCNKanMX6, a
plasmid containing loxP-kanMX-loxP module, were con-
structed from pFA6a-KanMX6 according to [48].
pTKURA3 were constructed by replacing the KanMX6
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nucleotides upstream and +77 nucleotides downstream
of URA3 gene. ADH1 gene was deleted by introduction
of linearized gene deletion cassette consisting of loxP-
URA3-loxP sequence flanked by the 45 nucleotides
upstream and downstream of ADH1 gene to BY4742
wild-type strain. ADH3, ADH5 or ALD6 genes were then
deleted in Δadh1 background using the same method to
construct double gene deletion strains B2C-a1a3, B2C-
a1a5 and B2C-a1a6. To construct the triple deletion
strains B2C-a1a3a6 and B2C-a1a5a6, ADH3 and ADH5
were again deleted separately from Δadh1 Δald6 back-
ground with the previously described method. Mean-
while, strain B2C-a1a3a5 was constructed by the
deletion of ADH3 from strain B2C-a1a5. Strain B2C-
a1a6g2 was constructed by the deletion of GPD2 gene
from strain B2C-a1a6. Further deletion of ADH3 and
ADH5 genes from strain B2C-a1a6g2 resulted in the
quintuple deletion strain B2C-a1a6g2a3a5. All strains
were verified by colony polymerase chain reaction (PCR)
with appropriate confirmation primers (Additional file
2). The aragose gel images of all gene deletion strains
are provided (Additional file 3).
Plasmid construction and transformation
The plasmids used in this study are listed in Table 4. S.
cerevisiae BDH1 gene was amplified from the genomic
DNA of BY4742 strain with the primers BDH1-F-
BamHI and BDH1-R-XhoI. The fragment amplified was
ligated to p423GPD and p423TEF that were digested
with BamHI and XhoI. The resulting construct is
p423GPD-BDH1 and p423TEF-BDH1. E. aerogenes
budC gene was amplified from the genomic DNA of E.
aerogenes KCTC 2190 strain by PCR using the primers
E.a.budC-F-BamHI and E.a.budC-R-EcoRV. budC gene
fragment was then inserted between the BamHI-EcoRV
sites of p423GPD, resulting in p423GPD-E.a.budC.
The GAL1/GAL10 promoter regions of pESC-URA
(Stratagene) were removed and replaced with the PGK1/
TEF1 divergent promoters by two-step cloning. PGK1
promoter sequence was amplified from the genomic
DNA of S. cerevisiae BY4742 wild-type strain with pri-
mers PGK1p-F-AatII-NotI and PGK1p-R-BamHI. It was
then digested with BamHI and NotI and cloned into
pESC-URA to produce pCP-URA. TEF1 promoter re-
gion was amplified from p425TEF with primers TEF1p-
R-NotI and TEF1p-F-AatII. The TEF1 promoter frag-
ment and pCP-URA were digested by AatII and NotI
and then ligated to each other. The new plasmid gener-
ated is pCTP-URA. Bacillus subtilis alsS gene was amp-
lified from the genomic DNA of B. subtilis using primers
B.s.alsS-F-NotI and B.s.alsS-R-BglII. Meanwhile, E. aero-
genes budA was amplified from the genomic DNA of E.
aerogenes KCTC 2190 strain with primers E.a.budA-F-BamHI and E.a.budA-R-XhoI. B. subtilis alsS and E.
aerogenes budA fragment were cloned into pCTP-URA
under the control of TEF1 promoter and PGK1 pro-
moter, respectively.
In all cases, PCR was performed using TaKaRa LA Taq
Polymerase with GC Buffer (Takara Bio Inc, Shiga,
Japan). Yeast strains were transformed using the lithium
acetate/PEG/SS-DNA method [49]. After transform-
ation, successful transformants were selected on SC
media without the appropriate amino acids.
Batch fermentations
For all fermentations, pre-cultures were prepared by in-
oculating 5 ml of SC medium in a 50 ml screw-capped
tube with a fresh colony grown on solid medium. Batch
fermentations were performed in 250 ml Erlenmeyer
flasks containing 50 ml of synthetic complete dropout
medium. Microaerobic condition was maintained in the
flasks by sealing with rubber stoppers. For anaerobic fer-
mentations, 50 ml of SC medium supplemented with
0.42 gl-1 Tween 80 and 0.01 gl-1 cholesterol in a 150 ml
serum bottle was purged with pure nitrogen gas for 15
minutes to establish anaerobic condition. Initial OD660nm
was adjusted at 0.05. Fermentations were performed in
shaking incubator at 30°C, with agitation at 250 rpm.
Analytical methods
Cell growth was determined by measuring the absorb-
ance at 660 nm using UV–VIS spectrophotometer (Shi-
mazu UV mini 1240, Tokyo, Japan). In addition, we
determined the dry cell mass of yeast at the end of
shake-flask cultivation by filtering 30 ml of culture
through pre-weighed cellulose acetate membrane filters
(Chmlab Group, Barcelona, Spain) with a pore size of
0.45 μm. Filters were dried at 65°C for 48 hours and
weighed again. Then, we calculated the dry cell mass
and estimated the cell biomass by using the dry cell
mass/OD660 ratio at the end of cultivation.
For extracellular metabolite analysis, 1 ml of culture
samples were collected at appropriate time point. Iso-
propyl alcohol was added to the 1 ml-sample as internal
standard and vortexed for 1 min. The samples were then
centrifuged (13500 rpm, 5 min) and 200 μl of superna-
tants were transferred to HPLC autosampler vials. Extra-
cellular concentrations of glucose, glycerol, ethanol,
acetate, succinate, acetoin and 2,3-butanediol were
determined with a high performance liquid chromatog-
raphy (HPLC) system (ACME-9000, Younglin Instru-
ment, Seoul, South Korea) equipped with a refractive
index detector (RID). Analytes were separated using
Sugar SH1011 column (Shodex, Tokyo, Japan) with
10 mM sulfuric acid as mobile phase pumped at
0.5mlmin-1. The column and the detector were set to
75°C and 45°C, respectively. The order of elution was
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butanediol, ethanol and isopropyl alcohol. For quantita-
tive analysis, standards for all metabolite at five different
concentration levels were prepared. A calibration curve
for each component was made and from these calibra-
tion curves concentrations of metabolites were calcu-
lated. The standard for 2,3-butanediol (≥99.0% (GC),
Fluka Analytical, Sigma-Aldrich) and the extracellular
2,3-butanediol from the fermentation samples are a mix-
ture of racemic and meso forms. Extracellular acetalde-
hyde concentrations were determined with Megazyme
Acetaldehyde Assay Kit (Megazyme International Ire-
land, Wicklow, Ireland) according to the manufacturer’s
instructions.
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